Clinical trials in Mycobacterium avium therapy: lessons to take home.
Dautzenberg
B
B
Groupe hospitalier Pitié-Salpêtrière, Paris.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D002648:Child; D017291:Clarithromycin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*; D015363:Quinolones / Q000627:therapeutic use; D017828:Rifabutin / Q000627:therapeutic use
D000995:Antitubercular Agents; D024841:Fluoroquinolones; D015363:Quinolones; D017828:Rifabutin; D004977:Ethambutol; D017291:Clarithromycin; C061363:sparfloxacin